Literature DB >> 3920276

Ultrasonic detection of lymph node metastases in the region around the celiac axis in esophageal and gastric cancer.

H Yoshinaka, M Nishi, T Kajisa, K Kuroshima, H Morifuji.   

Abstract

The celiac axis could be visualized with ultrasound in 140 out of 166 cases (84%). Failure to identify the celiac axis was associated with extensive metastases to the celiac lymph nodes in 73% (19/26) of these cases. The location of lymph nodes in this region could be determined using the celiac axis and its branches as land marks. Celiac lymph nodes can be roughly classified into three types: Type 1--unclear margins and relatively uniform diffuse internal echoes, Type 2--clear margins and weak internal echoes, and Type 3--clear margins and scattered, large internal echoes, frequently seen with notchings. Metastases in celiac lymph nodes were found in 53 of 166 cases, based on histological examination of surgically removed nodes. A preoperative ultrasonic examination indicated lymph node metastases in 39 out of the 53 cases (sensitivity of 74%) and no lymph node metastases in 108 of the remaining 113 cases (specificity of 96%). Most lymph nodes with metastases were of Types 2 or 3. The longer the diameter of the lymph node or the larger the ratio of metastatic area to node cross-sectional area, the higher the detection rate tended to be. These results indicate that ultrasound can be very useful in screening patients for celiac lymph node metastases.

Entities:  

Mesh:

Year:  1985        PMID: 3920276     DOI: 10.1002/jcu.1870130302

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  9 in total

1.  Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma.

Authors:  S Natsugoe; H Yoshinaka; M Shimada; F Sakamoto; T Morinaga; S Nakano; C Kusano; M Baba; S Takao; T Aikou
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

2.  A detailed histological study on occult metastasis of the lymph nodes.

Authors:  S Natsugoe; T Aiko; H Shimazu
Journal:  Jpn J Surg       Date:  1991-09

3.  Assessment of cervical lymph node metastasis in esophageal carcinoma using ultrasonography.

Authors:  S Natsugoe; H Yoshinaka; M Shimada; K Shirao; S Nakano; C Kusano; M Baba; T Fukumoto; S Takao; T Aikou
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

4.  Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma.

Authors:  Masanori Ikeda; Shoji Natsugoe; Shinichi Ueno; Masamichi Baba; Takashi Aikou
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

5.  Metastatic mode and DNA ploidy in gastric carcinoma.

Authors:  Y Umehara; T Kimura; M Yoshida; N Oba; Y Harada
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

6.  Efficiency of ultrasonography in assessing cervical lymph node metastasis in oral carcinoma.

Authors:  Saraswathi M C Dayanand; Rajendra Desai; Praveen B Reddy
Journal:  Natl J Maxillofac Surg       Date:  2010-07

7.  Preoperative evaluation of the curative resectability of gastric cancer by abdominal computed tomography and ultrasonography: a prospective comparison study.

Authors:  J J Kim; H C Jung; I S Song; K W Choi; C Y Kim; J K Han; B I Choi; J G Park; K U Lee; K J Choe; W H Kim
Journal:  Korean J Intern Med       Date:  1997-01       Impact factor: 2.884

8.  Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis.

Authors:  E P M van Vliet; E W Steyerberg; M J C Eijkemans; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2007-09-11       Impact factor: 7.640

9.  Number of Axillary Lymph Node Metastases Determined by Preoperative Ultrasound is Related to Prognosis in Patients with Breast Cancer.

Authors:  Yuko Kijima; Heiji Yoshinaka; Munetsugu Hirata; Tadao Mizoguchi; Sumiya Ishigami; Akihiro Nakajo; Hideo Arima; Shinichi Ueno; Shoji Natsugoe
Journal:  Cancers (Basel)       Date:  2010-02-04       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.